On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer

Journal of Pharmaceutical Sciences

Volumn 88, Issue 2, 1999, Pages 166-173

  Carrasquillo, Karen G ^a   Costantino, Henry R ^b,c   Cordero, Rocio A ^a   Hsu, Chung C ^b   Griebenow, Kai ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b GENENTECH INC   (United States)

^c ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROMETHANE; HUMAN GROWTH HORMONE; POLYGLACTIN; TREHALOSE;

ALPHA HELIX; ARTICLE; ENCAPSULATION; FREEZE DRYING; INFRARED SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE;

EID: 0032970303     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980272o     Document Type: Article

References (67)

1. Robinson, J. R. Controlled drug delivery. In Controlled Drug Delivery. Challenges and Strategies; Park, K., Ed.; American Chemical Society: Washington, DC, 1997; pp 1-7.
2. Pramik, M. J. Protein stability grows in importance as more biodrugs enter clinicals. Chem. Eng. News 1995, March 15.
3. Cleland, J. L.; Langer, R. Formulations and Delivery of Proteins and Peptides: Design and Development Strategies. In Formulation and delivery of proteins and peptides; Cleland, J. L., Langer, R., Eds.; ACS Symposium Series, ACS Books; pp 1-19.
4. Mrsny, R. J. Site-specific drug delivery in the gastrointestinal tract. In Controlled Drug Delivery. Challenges and Strategies; Park, K., Ed.; American Chemical Society: Washington, DC, 1997; pp 107-123.
5. Costantino, H. R.; Liauw, S.; Mitragotri, S.; Langer, R.; Klibanov, A. M.; Sluzky, V. The pharmaceutical development of insulin. Historical perspectives and future directions. In Therapeutic Protein and Peptide Formulation and Delivery; Shahrokh, Z.; Sluzky, V., Cleland, J. L., Shire, S. J., Randolph, T. W., Eds.; American Chemical Society: Washington, DC, 1997; pp 29-66.
6. Langer, R. New methods of drug delivery. Science 1990, 249, 1527-1533.
7. Langer, R. Biomaterials and biomedical engineering. Chem. Eng. Sci. 1995, 50, 4109-4121.
8. Schwendeman, S. P.; Costantino, H. R.; Gupta, R. K.; Langer, R. Peptide, protein, and vaccine delivery from implantable polymeric systems. Progress and challenges. In Controlled Drug Delivery. Challenges and Strategies; Park. K., Ed.; American Chemical Society: Washington, DC, 1997; pp 229-267.
9. 8].
10. Göpferich, A.; Langer, R. Modeling monomer release from bioerodible polymers. J. Controlled Release 1995, 33, 55-69.
11. Batycky, R. P.; Hanes, J.; Langer, R.; Edwards, D. A. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci. 1997, 86, 1464-1477.
12. Scholes, P. D.; Coombes, A. G. A.; Davies, M. C.; Ilium, L.; Davis, S. S. Particle engineering of biodegradable colloids for site-specific drug delivery. In Controlled Drug Delivery. Challenges and Strategies; Park, K., Ed.; American Chemical Society: Washington, DC, 1997; pp 73-106.
13. Johnson, O. L.; Jarorowicz, W.; Cleland, J. L.; Bailey, L.; Charnis, M.; Duenas, E.; Wu, C.; Shepard, D.; Magil, S.; Last, T.; Jones, A. J. S.; Putney, S. D. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 1997, 14, 730-735.
14. Manning, M. C.; Patel, K.; Borchardt, R. T. Stability of protein pharmaceuticals. Pharm. Res. 1989, 6, 903-918.
15. Volkin, D. B.; Klibanov, A. M. Minimizing protein inactivation. In Protein Function: A Practical Approach; Creighton, T., Ed.; Oxford University: New York, pp 1-24.
16. Schwendeman, S. P.; Cardamone, M.; Brandon, M. R.; Klibanov, A. M.; Langer, R. Stability of proteins and their delivery from biodegradable polymer microspheres. In Microparticulate Systems for the Delivery of Proteins and Vaccines; Cohen, S., Bernstein, H., Eds.; Marcel Dekker: New York, 1996; pp 1-49.
17. Schöneich, C.; Hageman, M. J.; Borchardt, R. T. Stability of peptides and proteins. In Controlled Drug Delivery. Challenges and Strategies; Park, K., Ed.; American Chemical Society: Washington, DC, 1997; pp 205-228.
18. Desai, U. R.; Klibanov, A. M. Assessing the structural integrity of a lyophilized protein in organic solvents. J. Am. Chem. Soc. 1995, 117, 3940-3945.
19. Griebenow, K.; Klibanov, A. M. On protein denaturation in aqueous - organic mixtures but not in pure organic solvents. J. Am. Chem. Soc. 1996, 118, 11695-11700.
20. Maa, Y.-F.; Hsu, C. C. Effect of high shear on proteins. Biotechnol. Bioeng. 1996, 51, 458-465.
21. Sluzky, V.; Tamada, J. A.; Klibanov, A. M.; Langer, R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 9377-9381.
22. Prestrelski, S. J.; Tedischi, N.; Arakawa, T.; Carpenter, J. F. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys. J. 1993, 65, 661-671.
23. Desai, U. R., Osterhout, J. J.; Klibanov, A. M. Protein structure in the lyophilized state: a hydrogen isotope exchange/NMR study with bovine pancreatic trypsin inhibitor. J. Am. Chem. Soc. 1994, 116, 9420-9422.
24. Dong, A.; Prestrelski, S. J.; Allison, S. D.; Carpenter, J. F. Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. J. Pharm. Sci. 1995, 84, 415-424.
25. Griebenow, K.; Klibanov, A. M. Lyophilization-induced changes in the secondary structure of proteins. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 10969-10976.
26. Liu, R.; Langer, R.; Klibanov, A. M. Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol. Bioeng. 1991, 37, 177-184.
27. Costantino, H. R.; Langer, R.; Klibanov, A. M. Solid-phase aggregation of proteins under pharmaceutically relevant conditions J. Pharm. Sci. 1994, 83, 1662-1669.
28. Costantino, H. R.; Schwendeman, S. P.; Griebenow, K.; Klibanov, A. M.; Langer, R. The secondary structure and aggregation of lyophilized tetanus toxoid. J. Pharm. Sci. 1996, 85, 1290-1293.
29. Costantino, H. R.; Griebenow, K.; Mishra, P.; Langer, R.; Klibanov, A. M. Fourier transform infrared (FTIR) spectroscopic investigation of protein stability in the lyophilized form. Biochim. Biophys. Acta 1995, 253, 69-74.
30. Costantino, H. R.; Carrasquillo, K. G.; Cordero, R. A.; Mumenthaler, M.; Hsu, C. C.; Griebenow K. G. The effect of excipients on the structure and stability of lyophilized recombinant human growth hormone (rhGH). J. Pharm. Sci. 1998, 87, 1412-1420.
31. Fu, K.; Griebenow, K.; Hsieh, L.; Klibanov, A. M.; Langer, R. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. J. Controlled Release, in press.
32. Dong, A.; Meyer, J. D.; Kendrick, B. S.; Manning, M. C.; Carpenter, J. F. Effect of secondary structure on the activity of enzymes suspended in organic solvents. Arch. Biochem. Biophys. 1996, 334, 406-414.
33. Griebenow, K.; Klibanov, A. M. Can conformational changes be responsible for solvent and excipient effects on the catalytic behavior of subtilisin Carlsberg in organic solvents? Biotechnol. Bioeng. 1997, 53, 351-362.
34. Overcashier, D. E.; Brooks, D. A.; Costantino, H. R.; Hsu, C. C. Preparation of excipient-free recombinant human tissue-type plasminogen activator by lyophilization from ammonium bicarbonate solution. An investigation of the two-stage sublimation phenomenon. J. Pharm. Sci. 1997, 86, 455-459.
35. Costantino, H. R.; Nguyen, T. H.; Hsu, C. C. Fourier transform infrared spectroscopy demonstrates that lyophilization alters the secondary structure of recombinant human growth hormone. Pharm. Sci. 1996, 2, 229-232.
36. Chan, H.-K.; Ongpipattanakul, B.; Au-Yeung, J. Aggregation of rhDNase occurred during the compression of KBr pellets used for FTIR spectroscopy. Pharm. Res. 1996, 13, 238-242.
37. Costantino, H. R.; Chen, B.; Griebenow, K.; Hsu, C. C.; Shire, S. J. Fourier transform infrared spectroscopic investigation of the secondary structure of aqueous and dried recombinant human deoxyribonuclease I. Pharm. Pharmacol. Commun. 1998, 4, 391-395.
38. Mantsch, H. H.; Casal, H. L.; Jones, R. N. Resolution enhancement of infrared spectra of biological systems. In Spectroscopy of Biological Systems, Clark, R. J. H.; Hester, R. E., Eds.; Wiley: New York, 1986; pp 1-46.
39. Susi, H.; Byler, D. M. Resolution-enhanced Fourier transform infrared spectroscopy of enzymes. Methods Enzymol. 1986, 130, 290-311.
40. Byler, D. M.; Susi, H. Examination of the secondary structure on proteins by deconvoluted FTIR spectra. Biopolymers 1986, 25, 469-487.
41. Görne-Tschelnokow, U.; Naumann, D.; Weise, C.; Hucho, F. Secondary structure and temperature behavior of acetylcholinesterase. Studies by Fourier transform infrared spectroscopy. Eur. J. Biochem. 1993, 213, 1235-1242.
42. Casal, H. L.; Köhler, U.; Mantsch, H. H. Structural and conformational changes of β-lactoglobulin B. An infrared spectroscopic study of the effect of pH and temperature. Biochim. Biophys. Acta 1988, 957, 11-20.
43. Heimburg, T.; Marsh, D. Investigation of secondary and tertiary structural changes of cytochrome c in complexes with anionic lipids using amide hydrogen exchange measurements. An FTIR study. Biophys. J. 1993, 65, 2408-2417.
44. De Vos, A. M.; Ultsch, M.; Kossiakoff, A. A. Human growth hormone and extracellular domain of its receptor. Crystal structure of the complex. Science 1992, 255, 306-312.
45. Wellner, N.; Belton, P. S.; Tatham, A. S. Fourier transform IR spectroscopic study of hydration-induced structure changes in the solid state of ω-gliadins. Biochem. J. 1996, 319, 741-747.
46. Maa, Y.-F.; Hsu, C. C. Effect of primary emulsions on microsphere size and protein-loading in the double emulsion process. J. Microencap. 1997, 14, 225-241.
47. Note that the artificial creation of bands by inappropriate subtraction of the PLGA background is excluded by demonstrating that the amide IFTIR spectra of rhGH co-lyophilized with trehalose were practically identical when measured as KBr pellets or encapsulated in PLGA. Furthermore, the spectra were very similar to that in aqueous solution. See Materials and Methods for details of the method used to subtract the PLGA background.
48. Colaço, C.; Sen, S.; Thangavelu, M.; Pinder, S.; Roser, B. Extraordinary stability of enzymes dried in trehalose: simplified molecular biology. Bio/Technology 1992, 10, 1007-1011.
49. Carpenter, J. F.; Crowe, J. H. An infrared spectroscopic study of the interaction of carbohydrates with dried proteins. Biochemistry 1989, 28, 3916-3922.
50. Belton, P. S.; Gil, A. M. IR and Raman spectroscopic studies of the interaction of trehalose with hen egg white lysozyme. Biopolymers 1994, 34, 957-961.
51. Carrasquillo, K. G.; Cordero, R. A.; Ho, S.; Franquiz, J. M.; Griebenow, K. Structure-guided encapsulation of bovine serum albumin in poly(D,L-lactic-co-glycolic)acid. Pharm. Pharmacol. Commun. 1998, 4, 563-571.
52. Zaks, A.; Klibanov, A. M. Enzymatic catalysis in nonaqueous solvents. J. Biol. Chem. 1988, 263, 3194-3201.
53. Klibanov, A. M. Enzymatic catalysis in anhydrous organic solvents. TIBS 1989, 14, 141-144.
54. Klibanov, A. M. Why are enzymes less active in organic solvents than in water? Trends Biotechnol. 1997, 15, 97-101.
55. Schmidtke, J. L.; Wescott, C. R.; Klibanov, A. M. The mechanistic dissection of the plunge in enzymatic activity upon transition from water to anhydrous solvents. J. Am. Chem. Soc. 1996, 118, 3360-3365.
56. Klibanov, A. M. What is remembered and why? Nature 1995, 374, 596.
57. Mishra, P.; Griebenow, K.; Klibanov, A. M. Structural basis for the molecular memory of imprinted proteins in anhydrous media. Biotechnol. Bioeng. 1996, 52, 609-614.
58. Rich, J. O.; Dordick, J. S. Controlling subtilisin activity and selectivity in organic media by imprinting with nucleophilic substrates. J. Am. Chem. Soc. 1997, 119, 3245-3252.
59. Zaks, A.; Klibanov, A. M. Enzymatic catalysis in organic media at 100 °C. Science 1984, 224, 1249-1251.
60. Volkin, D. B.; Straubli, A.; Langer, R.; Klibanov, A. M. Enzyme thermo-inactivation in anhydrous organic solvents. Biotechnol. Bioeng. 1991, 37, 843-853.
61. Burke, P. A.; Griffin, R. G.; Klibanov, A. M. Solid-state nuclear magnetic resonance investigation of solvent dependence of tyrosyl ring motion in an enzyme. Biotechnol. Bioeng. 1993, 42, 87-94.
62. Guinn, R. M.; Skerker, P. S.; Kavanaugh, P.; Clark, D. S. Activity and flexibility of alcohol dehydrogenase in organic solvents. Biotechnol. Bioeng. 1991, 37, 303-308.
63. Affleck, R.; Xu, Z.-F.; Suzawa, V.; Focht, K.; Clark, D. S.; Dordick, J. S. Enzymatic catalysis and dynamics in low-water environments. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 1100-1104.
64. Broos, J.; Visser, A. J. W.; Engbersen, J. F. J.; Verboom, W.; van Hoek, A.; Reinhoudt, D. N. Flexibility of enzymes suspended in organic solvents probed by time-resolved fluorescence anisotropy. Evidence that enzyme activity and enantioselectivity are directly related to enzyme flexibility. J. Am. Chem. Soc. 1995, 117, 12657-12663.
65. Hartsough, D. S.; Merz, K. M. Jr. Protein dynamics and solvation in aqueous and nonaqueous environments. J. Am. Chem. Soc. 1993, 115, 6529-6537.
66. Toba, S.; Merz, K. M. Jr. The concept of solvent compatibility and its impact on protein stability and activity enhancement in nonaqueous solvents. J. Am. Chem. Soc. 1997, 119, 9939-9948.
67. Barron, L. D.; Hecht, L.; Wilson, G. The lubrication of life: a proposal that solvent water promotes extremely fast conformational fluctuations in mobile heteropolymer structure. Biochemistry 1997, 36, 13143-13147.